56754
Electrolyte solution
nonaqueous, 2 M LiCl in ethanol
Synonym(s):
Lithium chloride solution
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Linear Formula:
LiCl
CAS Number:
Molecular Weight:
42.39
MDL number:
UNSPSC Code:
26111700
PubChem Substance ID:
NACRES:
NB.61
Recommended Products
quality
nonaqueous
Quality Level
concentration
2 M LiCl in ethanol
SMILES string
[Li+].[Cl-]
InChI
1S/ClH.Li/h1H;/q;+1/p-1
InChI key
KWGKDLIKAYFUFQ-UHFFFAOYSA-M
Looking for similar products? Visit Product Comparison Guide
Related Categories
General description
Visit our Sensor Applications portal to learn more.
Application
Filling solution for reference electrodes used for titrations in nonaqueous solutions.
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Flam. Liq. 2
Storage Class Code
3 - Flammable liquids
WGK
WGK 1
Flash Point(F)
53.6 °F
Flash Point(C)
12 °C
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Karla M Acevedo et al.
The Journal of biological chemistry, 289(16), 11007-11019 (2014-03-13)
Amyloid precursor protein (APP) undergoes post-translational modification, including O- and N-glycosylation, ubiquitination, and phosphorylation as it traffics through the secretory pathway. We have previously reported that copper promotes a change in the cellular localization of APP. We now report that
Ted M Hsu et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(2), 327-337 (2014-07-19)
Glucagon-like peptide-1 (GLP-1) is produced in the small intestines and in nucleus tractus solitarius (NTS) neurons. Activation of central GLP-1 receptors (GLP-1Rs) reduces feeding and body weight. The neural circuits mediating these effects are only partially understood. Here we investigate
Masaki Arioka et al.
Biochemical pharmacology, 90(4), 397-405 (2014-06-24)
Inhibition of glycogen synthase kinase (GSK)-3 and the consequent activation of the Wnt/β-catenin signaling pathway have been reported to increase bone volume. To develop a novel pharmacotherapy for injured bone, we investigated whether GSK-3 inhibitor was effective in promoting bone
Hector Vargas-Perez et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 34(23), 7899-7909 (2014-06-06)
Drug administration to avoid unpleasant drug withdrawal symptoms has been hypothesized to be a crucial factor that leads to compulsive drug-taking behavior. However, the neural relationship between the aversive motivational state produced by drug withdrawal and the development of the
Elizabeth G Mietlicki-Baase et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(2), 372-385 (2014-07-19)
Amylin acts in the CNS to reduce feeding and body weight. Recently, the ventral tegmental area (VTA), a mesolimbic nucleus important for food intake and reward, was identified as a site-of-action mediating the anorectic effects of amylin. However, the long-term
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service